Menu
Search
Home > Courses > Antiretroviral Management of HIV-Associated Neurocognitive Disorders

Antiretroviral Management of HIV-Associated Neurocognitive Disorders

Antiretroviral Management of HIV-Associated Neurocognitive Disorders
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 5/17/2011
Review Date: 5/17/2011
Presenter
  • Scott Letendre, MD
    Associate Professor of Medicine
    University of California, San Diego
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Summarize background data on differences between antiretroviral drugs in distribution into the CNS.
  2. Review the approach to estimating the distribution of antiretroviral regimens into the CNS.
  3. Review results of studies that have compared estimates of antiretroviral regimens to CNS outcomes, such as HIV RNA levels in cerebrospinal fluid or neurocognitive impairment.
  4. Suggest an approach to management of clinical patients for prevention and management of HAND.
Presenter Bio
Scott Letendre, MD
Scott Letendre, M.D., is an Associate Professor of Medicine in the Department of Medicine, Division of Infectious Diseases, at the University of California, San Diego. Dr. Letendre's research, performed primarily at UCSD's HIV Neurobehavioral Research Center, focuses on the impact on the brain of chronic infections, primarily HIV and HCV, and their treatment. He is also an active investigator in the UCSD unit of the AIDS Clinical Trials Group (ACTG), and is currently a member of both the national ACTG Neurology Subcommittee and the ACTG Dementia Focus Group.
PRN Learning Modules